Benzinga | Sep 22, 2021 12:00PM EDT

Roth Capital Initiates Coverage On Marrone Bio Innovations with Buy Rating, Announces Price Target of $2

Roth Capital analyst Gerry Sweeney initiates coverage on Marrone Bio Innovations (NASDAQ:MBII) with a Buy rating and announces Price Target of $2.